Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of combining aliskiren with amlodipine in patients with hypertension not adequately controlled by amlodipine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• NORVASC (amlodipine besylate)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-03-23